Facebook
X
LinkedIn
ForwardSeries date:
01/01/2026 - 12:00pm to 12/31/2026 - 1:00pm
COURSE DIRECTOR
Claudia Anderson, APRN, C.N.P., M.S.N.
Miriam Hobbs, APRN, C.N.P., D.N.P.
Heidi Kashat, APRN, C.N.P., M.S.N.
Heather Montane, P.A.-C., M.S.
DESCRIPTION
This program provides NPs, PAs and RNs with cutting-edge information on caring for patients in Oncology and Hematology for the novice and seasoned practitioner. Topics focus on practice changing research that guide treatment decisions, supportive care and comprehensive cancer care. This is often done through case-based approach.
In-Person and Live-Streamed; Monthly on Thursday from 12:00-1:00 p.m.
TARGET AUDIENCE
Allied Health Professionals, Nurses, Nurse Practitioners, Physicians, and Physician Assistants.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
Claudia Anderson, APRN, C.N.P., M.S.N.
Miriam Hobbs, APRN, C.N.P., D.N.P.
Heidi Kashat, APRN, C.N.P., M.S.N.
Heather Montane, P.A.-C., M.S.
DESCRIPTION
This program provides NPs, PAs and RNs with cutting-edge information on caring for patients in Oncology and Hematology for the novice and seasoned practitioner. Topics focus on practice changing research that guide treatment decisions, supportive care and comprehensive cancer care. This is often done through case-based approach.
In-Person and Live-Streamed; Monthly on Thursday from 12:00-1:00 p.m.
TARGET AUDIENCE
Allied Health Professionals, Nurses, Nurse Practitioners, Physicians, and Physician Assistants.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Integrate updates from new research findings in cancer patients care.
- Identify emerging research approaches and potential mechanism of action of novel therapies.
- Review pathophysiology related to hematologic and solid tumor malignancies.
- Integrate multidisciplinary care into the management of cancer treatment.
- Define toxicity related to cancer directed therapies and management strategies.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
Karthik Giridhar, M.D. - Honoraria - AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Exact Sciences Corporation, Gilead Sciences, Inc., GRAIL, Inc., NeoGenomics Laboratories, Novartis, Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Puma Biotechnology, TerSera Therapeutics, LLC
All relevant financial relationships have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Claudia Anderson, APRN, C.N.P., M.S.N.
Miriam Hobbs, APRN, C.N.P., D.N.P.
Heidi Kashat, APRN, C.N.P., M.S.N.
Heather Montane, P.A.-C., M.S.
Lois Harne (Coordinator)
Megan Kandler (Coordinator)
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.
QUESTIONS?
Contact Lois Harne and Lia Tipton.
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
Karthik Giridhar, M.D. - Honoraria - AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Exact Sciences Corporation, Gilead Sciences, Inc., GRAIL, Inc., NeoGenomics Laboratories, Novartis, Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Puma Biotechnology, TerSera Therapeutics, LLC
All relevant financial relationships have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Claudia Anderson, APRN, C.N.P., M.S.N.
Miriam Hobbs, APRN, C.N.P., D.N.P.
Heidi Kashat, APRN, C.N.P., M.S.N.
Heather Montane, P.A.-C., M.S.
Lois Harne (Coordinator)
Megan Kandler (Coordinator)
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.
QUESTIONS?
Contact Lois Harne and Lia Tipton.
Where did the idea for the course originate?:
Minnesota